Deciphera Pharmaceuticals Inc’s latest rating changes from various analysts

In a filing, Deciphera Pharmaceuticals Inc revealed its Chief Financial Officer Kelly Thomas Patrick unloaded Company’s shares for reported $47009.0 on Feb 16 ’24. In the deal valued at $15.62 per share,3,010 shares were sold. As a result of this transaction, Kelly Thomas Patrick now holds 80,350 shares worth roughly $1.19 million. Then, Sherman Matthew […]